Rise of Medical Tourism Shows Impact on Cosmetic Surgery Market
Plastic Surgeons Should Prepare for 'Globalization' of Cosmetic Surgery, Says Article in PRS Global Open
Arlington Heights, Ill. (October 29, 2013) – Would you consider traveling to Mexico or India for a less-expensive rhinoplasty or breast augmentation procedure? Many Americans are doing just that—and the trend is having an impact on the market for cosmetic plastic surgery, according to an article in Plastic and Reconstructive Surgery—Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).
The paper, by ASPS Member Surgeon Dr. Kevin C. Chung and Lauren E. Franzblau of the University of Michigan, discusses "the rise and transformation of the medical tourism industry, foreign and domestic forces that influence cosmetic surgical tourism, and the pros and cons for all involved parties." Chung and Franzblau write, "The rapid globalization of the industry also marks a fundamental shift in the world’s perception of elective procedures: patients are becoming consumers and these medical services are being viewed as commodities."
More 'Medical Tourists' Are Traveling for Cosmetic Surgery…
Traveling for medical care is nothing new—but in the past, people were more likely to travel from poor countries to obtain higher-quality care in wealthier countries. Today, prompted by the ease and relatively low costs of travel, more patients from the United States and other western countries are traveling to the developing world to access less-costly medical and surgical procedures. Because cosmetic plastic surgery procedures aren't covered by insurance, they make up a major part of the burgeoning medical tourism market.
Figures vary, but there's a consensus that medical tourism is growing rapidly: India alone may have more than one million medical tourists per year. Other countries with growing medical tourism industries include Mexico, Dubai, South Africa, Thailand and Singapore.
Prices for cosmetic surgery in these countries are typically much lower than at home. For example, a breast augmentation procedure that would cost $6,000 in the U.S. can be done for $2,200 in India. Even after the costs of airfare are factored in, having an operation overseas can be much less expensive.
In many countries, governments are working actively to foster their medical tourism industry. Some destinations even market procedures performed in resort-like settings, encouraging patients to combine a vacation with cosmetic surgery. Traveling abroad also lets patients recuperate privately, without anyone at home knowing that they've had plastic surgery.
…Raising Potential Concerns Over Safety and Quality
The growth of medical tourism may have a significant impact on the cosmetic surgery market in the U.S., but also raises concerns over physical safety and legal protection. Although destination countries promote the quality and safety of their procedures and facilities, there is often little evidence to support these claims.
"Because the practice of medical travel does not appear to be going away in the foreseeable future, plastic surgeons must understand the international market and learn to compete in it," Chung and Franzblau write. Since U.S. surgeons may find it hard to compete on price, effective strategies may include emphasizing superior quality and safety of care, or developing "niche markets" of procedures that can be profitably performed at home.
The authors emphasize that medical tourism "is not purely good or bad"—neither for patients nor the countries involved. Patients may be drawn by lower costs, but must consider the potential risks of undergoing surgery in a foreign country, as well as traveling after surgery. ASPS provides information for patients considering travel abroad for cosmetic surgery, including risks and follow-up care.
For the U.S. and other developed countries, medical tourism means fewer patients and less revenue—but may also bring increased opportunities for collaboration with rapidly modernizing countries in other parts of the world. Chung and Franzblau conclude, "To retain patients and be competitive in a global market, U.S. plastic surgery must be vigilant of the changes in medical tourism and must adapt accordingly."
About PRS Global Open
Plastic and Reconstructive Surgery—Global Open (PRS GO) (www.prsgo.com) is a companion journal to the American Society of Plastic Surgeons’ flagship publication, Plastic and Reconstructive Surgery. PRS GO is an open access, rigorously peer-reviewed, international journal focusing on global plastic and reconstructive surgery. PRS GO educates and supports plastic surgeons globally to provide the highest quality patient care and maintain professional and ethical standards through education, research, and advocacy.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. You can learn more and visit the American Society of Plastic Surgeons at www.plasticsurgery.org or www.facebook.com/PlasticSurgeryASPS and www.twitter.com/ASPS_news.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.